170 related articles for article (PubMed ID: 19729501)
1. A convenient enzyme-linked immunosorbent assay for rapid screening of anti-adeno-associated virus neutralizing antibodies.
Ito T; Yamamoto S; Hayashi T; Kodera M; Mizukami H; Ozawa K; Muramatsu S
Ann Clin Biochem; 2009 Nov; 46(Pt 6):508-10. PubMed ID: 19729501
[TBL] [Abstract][Full Text] [Related]
2. Enhanced transduction of mouse salivary glands with AAV5-based vectors.
Katano H; Kok MR; Cotrim AP; Yamano S; Schmidt M; Afione S; Baum BJ; Chiorini JA
Gene Ther; 2006 Apr; 13(7):594-601. PubMed ID: 16341060
[TBL] [Abstract][Full Text] [Related]
3. Immunity to adeno-associated virus vectors in animals and humans: a continued challenge.
Zaiss AK; Muruve DA
Gene Ther; 2008 Jun; 15(11):808-16. PubMed ID: 18385765
[TBL] [Abstract][Full Text] [Related]
4. Enhanced transduction of mouse bone marrow-derived dendritic cells by repetitive infection with self-complementary adeno-associated virus 6 combined with immunostimulatory ligands.
Aldrich WA; Ren C; White AF; Zhou SZ; Kumar S; Jenkins CB; Shaw DR; Strong TV; Triozzi PL; Ponnazhagan S
Gene Ther; 2006 Jan; 13(1):29-39. PubMed ID: 16136165
[TBL] [Abstract][Full Text] [Related]
5. Utility of PEGylated recombinant adeno-associated viruses for gene transfer.
Le HT; Yu QC; Wilson JM; Croyle MA
J Control Release; 2005 Nov; 108(1):161-77. PubMed ID: 16125817
[TBL] [Abstract][Full Text] [Related]
6. Titration of AAV-2 particles via a novel capsid ELISA: packaging of genomes can limit production of recombinant AAV-2.
Grimm D; Kern A; Pawlita M; Ferrari F; Samulski R; Kleinschmidt J
Gene Ther; 1999 Jul; 6(7):1322-30. PubMed ID: 10455443
[TBL] [Abstract][Full Text] [Related]
7. PEG conjugation moderately protects adeno-associated viral vectors against antibody neutralization.
Lee GK; Maheshri N; Kaspar B; Schaffer DV
Biotechnol Bioeng; 2005 Oct; 92(1):24-34. PubMed ID: 15937953
[TBL] [Abstract][Full Text] [Related]
8. Preclinical study on gene therapy of cervical carcinoma using adeno-associated virus vectors.
Kunke D; Grimm D; Denger S; Kreuzer J; Delius H; Komitowski D; Kleinschmidt JA
Cancer Gene Ther; 2000 May; 7(5):766-77. PubMed ID: 10830724
[TBL] [Abstract][Full Text] [Related]
9. Adeno-associated virus vectors for gene therapy.
Flotte TR; Carter BJ
Gene Ther; 1995 Aug; 2(6):357-62. PubMed ID: 7584109
[TBL] [Abstract][Full Text] [Related]
10. AAV vectors for hemophilia B gene therapy.
Chao H; Walsh CE
Mt Sinai J Med; 2004 Oct; 71(5):305-13. PubMed ID: 15543431
[TBL] [Abstract][Full Text] [Related]
11. Efficiency of eight different AAV serotypes in transducing rat myocardium in vivo.
Palomeque J; Chemaly ER; Colosi P; Wellman JA; Zhou S; Del Monte F; Hajjar RJ
Gene Ther; 2007 Jul; 14(13):989-97. PubMed ID: 17251988
[TBL] [Abstract][Full Text] [Related]
12. Gene therapy against an experimental glioma using adeno-associated virus vectors.
Okada H; Miyamura K; Itoh T; Hagiwara M; Wakabayashi T; Mizuno M; Colosi P; Kurtzman G; Yoshida J
Gene Ther; 1996 Nov; 3(11):957-64. PubMed ID: 8940635
[TBL] [Abstract][Full Text] [Related]
13. IGF-1 gene therapy to protect articular cartilage in a rat model of joint damage.
Izal I; Acosta CA; Ripalda P; Zaratiegui M; Ruiz J; Forriol F
Arch Orthop Trauma Surg; 2008 Feb; 128(2):239-47. PubMed ID: 17661064
[TBL] [Abstract][Full Text] [Related]
14. No evidence for germ-line transmission following prenatal and early postnatal AAV-mediated gene delivery.
Jakob M; Mühle C; Park J; Weiss S; Waddington S; Schneider H
J Gene Med; 2005 May; 7(5):630-7. PubMed ID: 15693035
[TBL] [Abstract][Full Text] [Related]
15. Integration of active human beta-galactosidase gene (100 kb) into genome using HSV/AAV amplicon vector.
Oehmig A; Cortés ML; Perry KF; Sena-Esteves M; Fraefel C; Breakefield XO
Gene Ther; 2007 Jul; 14(14):1078-91. PubMed ID: 17460718
[TBL] [Abstract][Full Text] [Related]
16. Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors.
Müller OJ; Leuchs B; Pleger ST; Grimm D; Franz WM; Katus HA; Kleinschmidt JA
Cardiovasc Res; 2006 Apr; 70(1):70-8. PubMed ID: 16448634
[TBL] [Abstract][Full Text] [Related]
17. Immunity to adeno-associated virus serotype 2 delivered transgenes imparted by genetic predisposition to autoimmunity.
Zhang YC; Powers M; Wasserfall C; Brusko T; Song S; Flotte T; Snyder RO; Potter M; Scott-Jorgensen M; Campbell-Thompson M; Crawford JM; Nick HS; Agarwal A; Ellis TM; Atkinson MA
Gene Ther; 2004 Feb; 11(3):233-40. PubMed ID: 14737082
[TBL] [Abstract][Full Text] [Related]
18. Circumvention of vector-specific neutralizing antibody response by alternating use of human and non-human adenoviruses: implications in gene therapy.
Moffatt S; Hays J; HogenEsch H; Mittal SK
Virology; 2000 Jun; 272(1):159-67. PubMed ID: 10873758
[TBL] [Abstract][Full Text] [Related]
19. Adeno-associated virus serotypes: vector toolkit for human gene therapy.
Wu Z; Asokan A; Samulski RJ
Mol Ther; 2006 Sep; 14(3):316-27. PubMed ID: 16824801
[TBL] [Abstract][Full Text] [Related]
20. Theodore E. Woodward Award. AAV-mediated gene transfer for hemophilia.
High KA
Trans Am Clin Climatol Assoc; 2003; 114():337-51; discussion 351-2. PubMed ID: 12813929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]